Bristol-Myers Squibb
BMY
BMY
2,214 hedge funds and large institutions have $113B invested in Bristol-Myers Squibb in 2019 Q4 according to their latest regulatory filings, with 491 funds opening new positions, 1,216 increasing their positions, 390 reducing their positions, and 57 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
22% more funds holding
Funds holding: 1,811 → 2,214 (+403)
8.54% less ownership
Funds ownership: 83.94% → 75.4% (-8.5%)
62% less call options, than puts
Call options by funds: $1.84B | Put options by funds: $4.81B
Holders
2,214
Holding in Top 10
106
Calls
$1.84B
Puts
$4.81B
Top Buyers
| 1 | +$3.46B | |
| 2 | +$2.71B | |
| 3 | +$1.79B | |
| 4 |
Renaissance Technologies
New York
|
+$1.57B |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$1.27B |
Top Sellers
| 1 | -$1.5B | |
| 2 | -$344M | |
| 3 | -$334M | |
| 4 |
PP
Prudential plc
London, England,
United Kingdom
|
-$224M |
| 5 |
MSE
MUFG Securities EMEA
London,
United Kingdom
|
-$167M |